Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh

Maria Clementine Martin

M.c.m. Klosterfrau Vertriebsgesellschaft M.b.h.

Harald Greve

Rainer Greve

Holger Miething

Anna-Maria Vestweber

Christian Nauert

Walter Duchatsch

The invention relates to the combined use of at least one monoterpene which can be applied systemically, in particular perorally, and at least one respiratory tract therapeutic agent which can be applied topically, in particular through inhalation, for the prophylactic and/or therapeutic treatment, in particular combination therapy and/or co-medication, of respiratory tract diseases, in particular bronchopulmonary diseases. Through the combined use of the systemic monoterpene with the topical, in particular inhaled respiratory tract therapeutic agent, the effect or efficiency of the topical or inhaled respiratory disease therapeutic agent can be increased significantly, in particular in a synergistic manner, on the one hand, and the required dosage thereof can be reduced significantly on the other hand, combined with the resulting advantages (e.g., avoidance or reduction of side effects).

Monoterpenes for treating respiratory diseases, in particular bronchopulmonary diseases

Monoterpenes for treating respiratory disorders, in particular bronchopulmonary disorders

A pharmaceutical preparation for the treatment of acute rhinitis contains, in combination and in physiological concentration, a) a sympathomimetic having a 2-imidazoline structure which is suitable for topical use or its physiologically acceptable salts; and b) a pantothenic functional compounds which is b1) pantothenol or its derivatives, in particular esters; and/or b2) pantothenic acid or its physiologically acceptable salts.

Pharmaceutical composition for treating acute rhinitis

Growing community of inventors

Düsseldorf, Germany

Harald Greve